RDY · Dr Reddys Laboratories Ltd · Documents

$14.15 +0.40 (+2.91%) At close · Oct 28 Q2 2026 earnings call transcript

Market Cap

$11.73B

833.07M

Volume · Oct 28 4.47M Avg daily vol (3M) 2.92M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2021-08-03	2021-08-02
6-K	—	2021-08-03	—
6-K	—	2021-08-02	—
6-K	—	2021-07-29	2021-07-28
6-K	—	2021-07-27	—
6-K	—	2021-07-27	—
6-K	—	2021-07-27	—
6-K	—	2021-07-07	—
6-K	—	2021-07-06	2021-07-03
6-K	—	2021-07-02	—
6-K	—	2021-07-01	2021-06-30
20-F	—	2021-06-30	2021-03-31
6-K	—	2021-06-29	—
6-K	—	2021-06-28	2021-06-25
6-K	—	2021-06-28	—
6-K	—	2021-06-24	—
6-K	—	2021-06-22	—
6-K	—	2021-06-15	—
6-K	—	2021-06-04	2021-06-03
6-K	—	2021-05-24	2021-05-23
6-K	—	2021-05-21	2021-05-19
6-K	—	2021-05-19	2021-05-18
6-K	—	2021-05-17	2021-05-15
6-K	—	2021-05-14	—
6-K	—	2021-05-14	—
6-K	—	2021-05-12	—
6-K	—	2021-05-10	2021-05-08
6-K	—	2021-05-03	2021-04-30
6-K	—	2021-04-29	—
6-K	—	2021-04-23	—
6-K	—	2021-04-13	—
6-K	—	2021-04-07	—
6-K	—	2021-04-01	—
6-K	—	2021-04-01	2021-03-31
6-K	—	2021-03-29	—
6-K	—	2021-03-22	2021-03-19
6-K	—	2021-03-10	—
6-K	—	2021-03-01	—
6-K	—	2021-02-22	—
6-K	—	2021-02-19	—
6-K	—	2021-02-18	—
6-K	—	2021-02-17	—
6-K	—	2021-02-03	2021-02-02
6-K	—	2021-02-02	—
6-K	—	2021-02-01	—
6-K	—	2021-01-29	—
6-K	—	2021-01-27	—
6-K	—	2021-01-15	—
6-K	—	2021-01-11	—
6-K	—	2021-01-11	—

Showing 601–650 of 745 filings

Key facts CIK 1135951 CUSIP 256135203 13F (30d) 59 filings 54 filers Visit website Investor relations